Status:

RECRUITING

Therapeutic-educational Physiotherapy on Pain, Physical-functionality and Quality of Life in Women With Endometriosis.

Lead Sponsor:

University of Valencia

Collaborating Sponsors:

Hospital Universitario La Fe

Instituto de Investigacion Sanitaria La Fe

Conditions:

Endometriosis

Chronic Pain

Eligibility:

FEMALE

18-45 years

Phase:

NA

Brief Summary

This is a randomized clinical trial that will be carried out in women with endometriosis divided into two groups: the experimental group (EG) that will receive therapeutic-educational physiotherapy, w...

Eligibility Criteria

Inclusion

  • Diagnosis of endometriosis made by imaging techniques (MRI or ultrasound) or by surgery.
  • A period of 3 months or more since the last surgery if they have undergone surgery.
  • Who are receiving hormone treatment and have their disease under control.
  • Persistent pelvic pain for at least 3 months.
  • With pain and hypertonus in the pelvic musculature, myofascial syndrome, vestibulodynia or pudendal neuropathy.
  • Consent to participate in the study
  • Capable of carrying out the follow-up of the study until the final visit.
  • Who have audiovisual resources and the internet at their disposal.

Exclusion

  • Women in the menopausal phase
  • Women undergoing fertility treatment or planning to undergo fertility treatment in the next 3 months.
  • Pregnant women.
  • Women undergoing physiotherapy treatment or who have undergone physiotherapy treatment in the last 3 months.
  • Having suffered a fracture in the last 3 months in the lower limb that limits their functional capacity.
  • Cognitive illness that prevents correct comprehension of the exercises.
  • Musculoskeletal pathology or neuropathy in acute phase.
  • Having suffered or suffering from a neoplastic disease.
  • Untreated endometriosis
  • Acquired genital abnormalities of the pelvis or pelvic floor.
  • Women in a situation of litigation or economic compensation, or pending the granting of a degree of disability.
  • Severe mental illness (schizophrenia, borderline personality disorder, etc.)

Key Trial Info

Start Date :

February 9 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 22 2026

Estimated Enrollment :

62 Patients enrolled

Trial Details

Trial ID

NCT06212349

Start Date

February 9 2024

End Date

December 22 2026

Last Update

January 15 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Hospital Universitari i Politècnic La Fe,

Valencia, Spain, 46026